MASSACHUSETTS GENERAL HOSPITAL

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1811-01-01

Employees: -

Market Cap: -

Website: http://www.massgeneral.org/international

Clinical Trials

Effectiveness of a Computer Application in Improving Pulmonary Artery Catheter Waveform Interpretation

Not Applicable

Terminated

Conditions: Pulmonary Artery Catheter Waveform Interpretation

Interventions: Device: Web-based waveform interpretation guide

First Posted Date: 2005-08-30

Last Posted Date: 2014-06-30

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 55

Registration Number: NCT00138073

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Anastrozole Administration in Elderly Hypogonadal Men

Phase 2

Completed

Conditions: Hypogonadism

Interventions: Drug: anastrozole

First Posted Date: 2005-08-29

Last Posted Date: 2022-09-13

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 88

Registration Number: NCT00136695

Locations: 🇺🇸
General Clinical Research Center, Massachusetts General Hospital, Boston, Massachusetts, United States

A Safety and Efficacy Study of Alefacept in the Treatment of Moderate to Severe Erosive Mucosal Lichen Planus

Phase 2

Terminated

Conditions: Lichen Planus

Interventions: Drug: Amevive (Alefacept)
Drug: Placebo

First Posted Date: 2005-08-26

Last Posted Date: 2009-02-12

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 13

Registration Number: NCT00135733

Locations: 🇺🇸
Clinical Unit for Research Trials in Skin, Boston, Massachusetts, United States

Growth Hormone Administration and Its Effects on Cardiovascular Risk Factors in Growth Hormone Deficient Women

Not Applicable

Completed

Conditions: Growth Hormone Deficiency

Interventions: Drug: Placebo
Drug: Somatropin

First Posted Date: 2005-08-26

Last Posted Date: 2008-02-18

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 63

Registration Number: NCT00136032

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Study of Etanercept (Enbrel) in the Treatment of Pemphigus Vulgaris

Phase 2

Completed

Conditions: Pemphigus Vulgaris

First Posted Date: 2005-08-26

Last Posted Date: 2015-06-03

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 12

Registration Number: NCT00135720

Locations: 🇺🇸
Clinical Unit for Research Trials in Skin, Boston, Massachusetts, United States

Improving Pediatric Safety and Quality With Health Care Information Technology

Not Applicable

Completed

Conditions: Medication Errors
Medical Records Systems, Computerized
Patient Safety
Quality Improvement

Interventions: Other: weight based dosing decision support

First Posted Date: 2005-08-25

Last Posted Date: 2011-07-21

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 5420

Registration Number: NCT00134823

Locations: 🇺🇸
Massachusetts General Hospital/Partners HealthCare, Boston, Massachusetts, United States

Testing the Right Question Project (RQP) Health Education Strategy in a Mental Health Setting

Not Applicable

Completed

Conditions: Diagnosis, Psychiatric

Interventions: Behavioral: RQP patient health education module

First Posted Date: 2005-08-25

Last Posted Date: 2016-06-03

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 231

Registration Number: NCT00134615

Locations: 🇺🇸
MGH Chelsea Healthcare Center, Chelsea, Massachusetts, United States
🇺🇸
Windsor Street Health Center, Cambridge, Massachusetts, United States

Study of Unrelated Cord Blood Transplantation Using Tacrolimus and Sirolimus

Phase 2

Completed

Conditions: Multiple Myeloma
Myelogenous Leukemia
Non-Hodgkin's Lymphoma
Hodgkin's Disease
Lymphoblastic Leukemia

First Posted Date: 2005-08-23

Last Posted Date: 2016-07-25

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 32

Registration Number: NCT00133367

Locations: 🇺🇸
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Growth Hormone, Cardiovascular Risk, and Visceral Adiposity

Not Applicable

Completed

Conditions: Obesity

Interventions: Drug: Placebo Growth Hormone
Drug: Nutropin AQ growth hormone

First Posted Date: 2005-08-18

Last Posted Date: 2016-03-11

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 142

Registration Number: NCT00131378

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Carboplatin Taxol Avastin in Ovarian Cancer (OVCA)

Phase 2

Completed

Conditions: Ovarian Cancer

Interventions: Drug: Paclitaxel
Drug: Carboplatin
Drug: Bevacizumab

First Posted Date: 2005-08-12

Last Posted Date: 2016-06-01

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 62

Registration Number: NCT00129727

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy